Menogaril, an Anthracycline Compound with a Novel Mechanism of Action: Cellular Pharmacology

Menogaril, an anthracycline compound possessing a significant antitumor activity after both po and iv administration, has been introduced into clinical trials. However, its mechanism of action has not been clarified yet. This study revealed that its cytotoxicity correlated very well with the inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wierzba, Konstanty, Sugimoto, Yoshikazu, Matsuo, Ken‐ichi, Toko, Toshiyuki, Takeda, Setsuo, Yamada, Yuji, Tsukagoshi, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1990
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918082/
https://www.ncbi.nlm.nih.gov/pubmed/2144516
http://dx.doi.org/10.1111/j.1349-7006.1990.tb02654.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918082/
https://www.ncbi.nlm.nih.gov/pubmed/2144516
http://dx.doi.org/10.1111/j.1349-7006.1990.tb02654.x

Ejemplares similares